Status:
TERMINATED
Improved Prediction of Recurrent Stroke and Detection of Small Volume Stroke
Lead Sponsor:
UMC Utrecht
Collaborating Sponsors:
Dutch Heart Foundation
Netherlands Organisation for Scientific Research
Conditions:
Ischemic Stroke
Eligibility:
All Genders
18+ years
Brief Summary
Rationale: Over 20.000 people suffer an ischemic stroke in the Netherlands each year. Large artery occlusions are easy to identify and can be treated with endovascular clot removal. 70% of patient wil...
Eligibility Criteria
Inclusion
- Age ≥18 years;
- Time from symptom onset until imaging is \<9 hours\*;
- Clinical diagnosis of acute ischemic stroke or TIA;
- Informed consent from patient or family after the admission scan (unless the patient died).
- Patients who awaken with stroke symptoms can only be included if they went to sleep without any stroke symptoms and the time from going to sleep until imaging is less than 9 hours.
Exclusion
- Patients with another diagnosis such as intracerebral hemorrhage, subarachnoid hemorrhage or tumor;
- Patients with known contrast allergy or renal failure.
Key Trial Info
Start Date :
January 23 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2024
Estimated Enrollment :
439 Patients enrolled
Trial Details
Trial ID
NCT04019483
Start Date
January 23 2018
End Date
February 1 2024
Last Update
May 17 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam UMC, location AMC
Amsterdam, North Holland, Netherlands, 1105 AZ
2
St. Antonius Hospital
Nieuwegein, Utrecht, Netherlands, 3435 CM
3
University Medical Center Utrecht
Utrecht, Netherlands, 3584 CX